Properties of recombinant human plasma procarboxypeptidase U produced in mammalian and insect cells

Clinica Chimica Acta

Volumn 347, Issue 1-2, 2004, Pages 49-59

  Strömqvist, Mats ^a   Hansson, Lennart ^a   Andersson, Jan Olof ^a   Johansson, Thord ^a   Edlund, Michael ^a   Enoksson, Maria ^a   Goossens, Filip ^b   Scharpé, Simon ^b   Hendriks, Dirk ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Carboxypeptidase U; CPU; Fibrinolysiss; Mammalian cell expression; TAFI

Indexed keywords

RECOMBINANT ENZYME; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME GLYCOSYLATION; ENZYME MODIFICATION; ENZYME SYNTHESIS; HUMAN; INSECT CELL; MAMMAL CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CARBOXYPEPTIDASE U; CELL LINE; CHROMATOGRAPHY, AFFINITY; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME PRECURSORS; GLYCOSYLATION; HUMANS; INSECTS; ISOELECTRIC FOCUSING; LECTINS; MAMMALS; MASS SPECTROMETRY; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

INSECTA; MAMMALIA;

EID: 4143068087     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.03.027     Document Type: Article

References (35)

1. Hendriks D., Scharpé S., van Sande M., Lommaert M.P. Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N. J. Clin. Chem. Clin. Biochem. 27:1989;277-285
2. Hendriks D., Wang W., Scharpé S., Lommaert M.P., van Sande M. Purification and characterization of a new arginine carboxypeptidase in human serum. Biochim. Biophys. Acta. 1034:1990;86-92
3. Campbell W., Okada H. An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem. Biophys. Res. Commun. 162:1989;933-939
4. Eaton D.L., Malloy B.E., Tsai S.P., Henzel W., Drayna D. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J. Biol. Chem. 266:1991;21833-21838
5. Bajzar L., Manuel R., Nesheim M.E. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 270:1995;14477-14484
6. Wang W., Hendriks D.F., Scharpé S.S. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J. Biol. Chem. 269:1994;15937-15944
7. Bajzar L., Nesheim M.E., Tracy P.B. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood. 88:1996;2093-2100
8. Schatteman K., Goossens F., Scharpé S., Hendriks D. Proteolytic activation of purified human procarboxypeptidase U. Clin. Chim. Acta. 292:2000;25-40
9. Bajzar L., Morser J., Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271:1996;16603-16608
10. Broze G.J. Jr., Higuchi D.A. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood. 88:1996;3815-3823
11. Minnema M.C., Friederich P.W., Levi M., dem Borne P.A., Mosnier L.O., Meijers J.C., et al. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor: XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor. J. Clin. Invest. 101:1998;10-14
12. Redlitz A., Nicolini F.A., Malycky J.L., Topol E.J., Plow E.F. Inducible carboxypeptidase activity. A role in clot lysis in vivo. Circulation. 93:1996;1328-1330
13. Skidgel R.A., Erdös E.G. Cellular carboxypeptidases. Immunol. Rev. 161:1998;129-141
14. MEROPS Database (www.merops.co.uk).
15. Boffa M.B., Reid T.S., Joo E., Nesheim M.E., Koschinsky M.L. Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B). Biochemistry. 38:1999;6547-6558
16. Boffa M.B., Wang W., Bajzar L., Nesheim M.E. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties. J. Biol. Chem. 23:1998;2127-2135
17. Hansson L., Bläckberg L., Edlund M., Lundberg L., Stromqvist M., Hernell O. Recombinant human milk bile salt-stimulated lipase. Catalytic activity is retained in the absence of glycosylation and the unique proline-rich repeats. J. Biol. Chem. 268:1993;26692-26698
18. Pavlakis G.N., Hamer D.H. Regulation of a metallothionein-growth hormone hybrid gene in bovine papilloma virus. Proc. Natl. Acad. Sci. U. S. A. 80:1983;397-401
19. Sarver N., Byrne J.C., Howley P.M. Transformation and replication in mouse cells of a bovine papillomavirus-pML2 plasmid vector that can be rescued in bacteria. Proc. Natl. Acad. Sci. U. S. A. 79:1982;7147-7151
20. Graham F.L., van der Eb A.J. Transformation of rat cells by DNA of human adenovirus 5. Virology. 52:1973;456-467
21. Wang W., Hendriks D.F., Scharpé S.S. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J. Biol. Chem. 269:1994;15937-15944
22. Deutsch D.G., Mertz E.T. Plasminogen: purification from human plasma by affinity chromatography. Science. 170:1970;1095-1096
23. Wallen P., Wiman B. Characterization of human plasminogen: I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations. Biochim. Biophys. Acta. 20:1970;20-30
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 15:1970;680-685
25. Hendriks D., Scharpé S., van Sande M. Assay of carboxypeptidase N activity in serum by liquid-chromatographic determination of hippuric acid. Clin. Chem. 31:1985;1936-1939
26. Steed P.M., Lasala D., Liebman J., Wigg A., Clark K., Knap A.K. Characterization of recombinant human cathepsin B expressed at high levels in baculovirus. Protein Sci. 7:1998;2033-2037
27. Lacroix M., Ebel C., Kardos J., Dobo J., Gal P., Zavodszky P., et al. Assembly and enzymatic properties of the catalytic domain of human complement protease C1r. J. Biol. Chem. 276:2001;36233-36240
28. Strömqvist M., Falk P., Bergström S., Hansson L., Lönnerdal B., Normark S., et al. Human milk kappa-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa. J. Pediatr. Gastroenterol. Nutr. 21:1995;288-296
29. Altmann F., Staudacher E., Wilson I.B., Marz L. Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj. J. 16:1999;109-123
30. Nesheim M., Wang W., Boffa M., Nagashima M., Morser J., Bajzar L. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb. Haemost. 78:1997;386-391
31. Bajzar L., Nesheim M., Tracy P.B. The profibrinolytic effect of activated protein C in clots form from plasma is TAFI-dependent. Blood. 88:1996;2093-2100
32. Mosnier L.O., Meijers J.C., Bouma B.N. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb. Haemost. 85:2001;5-11
33. Mosnier L.O., Elisen M.G., Bouma B.N., Meijers J.C. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down-regulation of TAFI activation. Thromb. Haemost. 86:2001;1057-1064
34. Parekh R.B. Mammalian cell gene expression: protein glycosylation. Curr. Opin. Biotechnol. 2:1991;730-734
35. Strömqvist M., Schatteman K., Leurs J., Verkerk R., Andersson J.O., Johansson T., et al. Immunological assay for the determination of procarboxypeptidase U antigen levels in human plasma. Thromb. Haemost. 85:2001;12-17